• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新型 AS1411 适体的三链结口袋 DNA 纳米结构载多柔比星用于体外和体内靶向癌细胞。

A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.

机构信息

Research Institute of Sciences and New Technology , Mashhad 91778-99191 , Iran.

出版信息

Mol Pharm. 2018 May 7;15(5):1972-1978. doi: 10.1021/acs.molpharmaceut.8b00124. Epub 2018 Apr 23.

DOI:10.1021/acs.molpharmaceut.8b00124
PMID:29669200
Abstract

Active targeting of nanostructures containing chemotherapeutic agents can improve cancer treatment. Here, a three-way junction pocket DNA nanostructure was developed for efficient doxorubicin (Dox) delivery into cancer cells. The three-way junction pocket DNA nanostructure is composed of three strands of AS1411 aptamer as both a therapeutic aptamer and nucleolin target, the potential biomarker of prostate (PC-3 cells) and breast (4T1 cells) cancers. The properties of the Dox-loaded three-way junction pocket DNA nanostructure were characterized and verified to have several advantages, including high serum stability and a pH-responsive property. Cellular uptake studies showed that the Dox-loaded DNA nanostructure was preferably internalized into target cancer cells (PC-3 and 4T1 cells). MTT cell viability assay demonstrated that the Dox-loaded DNA nanostructure had significantly higher cytotoxicity for PC-3 and 4T1 cells compared to that of nontarget cells (CHO cells, Chinese hamster ovary cell). The in vivo antitumor effect showed that the Dox-loaded DNA nanostructure was more effective in prohibition of the tumor growth compared to free Dox. These findings showed that the Dox-loaded three-way junction pocket DNA nanostructure could significantly reduce the cytotoxic effects of Dox against nontarget cells.

摘要

主动靶向含有化疗药物的纳米结构可以改善癌症治疗。在这里,开发了一种三链结口袋 DNA 纳米结构,用于将阿霉素(Dox)高效递送至癌细胞。三链结口袋 DNA 纳米结构由三条 AS1411 适体组成,作为治疗适体和核仁素的靶标,核仁素是前列腺(PC-3 细胞)和乳腺癌(4T1 细胞)的潜在生物标志物。负载 Dox 的三链结口袋 DNA 纳米结构的性质进行了表征和验证,具有几个优点,包括高血清稳定性和 pH 响应性。细胞摄取研究表明,负载 Dox 的 DNA 纳米结构更优先被靶癌细胞(PC-3 和 4T1 细胞)内化。MTT 细胞活力测定表明,负载 Dox 的 DNA 纳米结构对 PC-3 和 4T1 细胞的细胞毒性明显高于非靶细胞(CHO 细胞,中国仓鼠卵巢细胞)。体内抗肿瘤作用表明,与游离 Dox 相比,负载 Dox 的 DNA 纳米结构更能有效抑制肿瘤生长。这些发现表明,负载 Dox 的三链结口袋 DNA 纳米结构可以显著降低 Dox 对非靶细胞的细胞毒性作用。

相似文献

1
A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.基于新型 AS1411 适体的三链结口袋 DNA 纳米结构载多柔比星用于体外和体内靶向癌细胞。
Mol Pharm. 2018 May 7;15(5):1972-1978. doi: 10.1021/acs.molpharmaceut.8b00124. Epub 2018 Apr 23.
2
Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.基于 AS1411 和 FOXM1 适体的十字形 DNA 纳米结构靶向递送至癌细胞的阿霉素。
Expert Opin Drug Deliv. 2018 Nov;15(11):1045-1052. doi: 10.1080/17425247.2018.1530656. Epub 2018 Oct 5.
3
A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.一种包含阿霉素和AS1411适配体的用于靶向乳腺癌细胞的多层DNA纳米结构。
J Drug Target. 2022 Dec;30(10):1106-1112. doi: 10.1080/1061186X.2022.2094387. Epub 2022 Jul 3.
4
Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.提高化疗效果:利用 AS1411 适体和壳聚糖包覆的 CuS 纳米粒子将阿霉素靶向递送至癌细胞。
J Pharm Sci. 2024 Jul;113(7):1865-1873. doi: 10.1016/j.xphs.2024.02.005. Epub 2024 Feb 10.
5
Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.基于多功能适体的纳米颗粒用于靶向药物递送以规避癌症耐药性
Biomaterials. 2016 Jun;91:44-56. doi: 10.1016/j.biomaterials.2016.03.013. Epub 2016 Mar 10.
6
Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.细胞表面核仁素作为一种有前景的受体,可实现AS1411适配体介导的有效靶向药物递送至癌细胞。
Curr Drug Deliv. 2018;15(9):1323-1329. doi: 10.2174/1567201815666180724104451.
7
Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.用于转移性乳腺癌模型中靶向药物递送和磁共振/荧光成像的多模态聚合物囊泡的合成。
Int J Pharm. 2020 Mar 30;578:119091. doi: 10.1016/j.ijpharm.2020.119091. Epub 2020 Jan 30.
8
Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.壳聚糖-金纳米粒子载阿霉素与核仁素适体共递物用于协同治疗癌细胞的 Forkhead box M1 适配体
Carbohydr Polym. 2020 Nov 15;248:116735. doi: 10.1016/j.carbpol.2020.116735. Epub 2020 Jul 7.
9
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.基于适体引导的 Holliday 连接点负载多柔比星的结肠癌靶向治疗。
Int J Nanomedicine. 2020 Mar 27;15:2119-2129. doi: 10.2147/IJN.S240083. eCollection 2020.
10
Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo.核仁素适体功能化 pH 响应型生物相容性纳米递药系统靶向共递送 FOXM1 适体和 DOX 以增强乳腺癌的治疗效果:体外和体内。
Drug Deliv Transl Res. 2024 Jun;14(6):1535-1550. doi: 10.1007/s13346-023-01495-5. Epub 2023 Dec 31.

引用本文的文献

1
Identification of a non-inhibitory aptameric ligand to CRL2 E3 ligase for targeted protein degradation.鉴定一种靶向蛋白降解的CRL2 E3连接酶非抑制性适体配体。
Nat Commun. 2025 Mar 13;16(1):2494. doi: 10.1038/s41467-025-57823-5.
2
Progressive cancer targeting by programmable aptamer-tethered nanostructures.通过可编程适配体连接的纳米结构对进展期癌症进行靶向治疗。
MedComm (2020). 2024 Oct 20;5(11):e775. doi: 10.1002/mco2.775. eCollection 2024 Nov.
3
Advancements in Aptamer-Driven DNA Nanostructures for Precision Drug Delivery.适体驱动 DNA 纳米结构在精准药物递送上的进展。
Adv Sci (Weinh). 2024 Jul;11(26):e2401617. doi: 10.1002/advs.202401617. Epub 2024 May 7.
4
Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers.利用经AS1411和ATP适配体修饰的金纳米颗粒将阿霉素和治疗性FOXM1适配体靶向递送至肿瘤细胞。
Iran J Basic Med Sci. 2023;26(10):1177-1187. doi: 10.22038/IJBMS.2023.71129.15452.
5
Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery.以DNA折纸术为主导的DNA纳米结构在抗肿瘤药物递送中的高级应用。
Front Mol Biosci. 2023 Aug 7;10:1239952. doi: 10.3389/fmolb.2023.1239952. eCollection 2023.
6
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer.前列腺癌联合靶向治疗与免疫治疗的机制及效果的新见解与选择
Mol Ther Oncolytics. 2023 Apr 29;29:91-106. doi: 10.1016/j.omto.2023.04.007. eCollection 2023 Jun 15.
7
Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery.使用适配体功能化纳米载体进行高级癌症靶向以实现位点特异性药物递送。
Biomater Res. 2023 May 6;27(1):42. doi: 10.1186/s40824-023-00365-y.
8
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.基于DNA的纳米材料作为药物递送平台以增强药物在肿瘤中的疗效。
Cancers (Basel). 2023 Apr 5;15(7):2151. doi: 10.3390/cancers15072151.
9
Novel targeted pH-responsive drug delivery systems based on PEGMA-modified bimetallic Prussian blue analogs for breast cancer chemotherapy.基于聚乙二醇甲基丙烯酸酯修饰的双金属普鲁士蓝类似物的新型靶向pH响应性药物递送系统用于乳腺癌化疗。
RSC Adv. 2023 Jan 9;13(3):1684-1700. doi: 10.1039/d2ra06631a. eCollection 2023 Jan 6.
10
Aptamer-Based Probes for Cancer Diagnostics and Treatment.用于癌症诊断与治疗的基于适配体的探针。
Life (Basel). 2022 Nov 21;12(11):1937. doi: 10.3390/life12111937.